Status:
COMPLETED
Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients
Lead Sponsor:
Karolinska Institutet
Conditions:
Covid-19
Thromboembolic Events
Eligibility:
All Genders
Brief Summary
The aims of the study are to to associate anticoagulation (AC) regime with outcome in critically ill patients with Covid-19. This will be done by describe baseline characteristics and comorbidities be...
Eligibility Criteria
Inclusion
- laboratory confirmed positive test for SARS-CoV-2
- admitted to ICU because of critical illness due to covid-19
Exclusion
- patients with treatment for thromboembolic complications at arrival to the ICU
- short ICU length of stay defined as discharged the same or the following day as ICU admission
Key Trial Info
Start Date :
March 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 28 2020
Estimated Enrollment :
166 Patients enrolled
Trial Details
Trial ID
NCT04412304
Start Date
March 6 2020
End Date
May 28 2020
Last Update
June 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South General Hospital
Stockholm, Stockholm County, Sweden, 11880